The Impact of the FXR1-FUBP1 Axis on Chemotherapy Resistance in LUSC Cells

  • Biochem Genet. 2025 Nov 22. doi: 10.1007/s10528-025-11290-1.
Renji Liang  1 ,  Yuehua Li  2 ,  Jiayang Chen  1 ,  Hao Deng  3
Affiliations
  • 1. Department of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China.
  • 2. Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
  • 3. Department of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China. [email protected].
PMID: 41273664 DOI: 10.1007/s10528-025-11290-1
Keywords
Chemotherapy resistance; FUBP1; FXR1; Immune evasion; Lung cancer.
Products
Inhibitors & Agonists
Other Products